EGFR Expression and Survival in Patients Given Cetuximab and Chemoradiation for Stage III Non-Small Cell Lung Cancer: A Secondary Analysis of RTOG 0324

PURPOSE: We investigated whether expression of epidermal growth factor receptor (EGFR) was associated with survival and disease control in this secondary analysis of a phase II trial of cetuximab+chemoradiation for stage III non-small cell lung cancer. METHODS: Patients received cetuximab weekly bef...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Komaki, Ritsuko, Paulus, Rebecca, Blumenschein, George R, Curran, Walter J., Robert, Francisco, Thariat, Juliette, Werner-Wasik, Maria, Choy, Hak, Hirsch, Fred R., Ang, K. Kian
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4169722/
https://ncbi.nlm.nih.gov/pubmed/25042878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2014.06.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados